The trajectory of base editing has been remarkable, progressing from the laboratory to patient care, treating debilitating or ...
Funding will expand the range of Dualase® genome editors for new high morbidity and mortality genetic disease targets.TORONTO, 2026 /CNW/ - ...
Analysis of hundreds of environmental exposures and health outcomes quantifies influence of nongenetic factors ...
For decades, scientists have been carefully unraveling the role of genes in disease by examining how small variations in a ...
Chantez Sanford Jr., 24, of Southfield, says his life has been transformed after undergoing Lyfgenia gene therapy at Children ...
Rutgers-Newark researchers have shown that a genetic variant specific to African ancestry alters the brain in a way that could foretell the eventual development of Alzheimer's Disease. At the same ...
Beyond seizures: With experimental drug, Stoke aims to restore developmental loss in Dravet syndrome
Stoke Therapeutics is developing a drug designed to reduce seizures and restore some of their lost developmental function.
Gaucher disease is a rare inherited disorder in which fatty substances accumulate inside certain cells, gradually damaging organs such as the spleen, liver and bones. The condition occurs due to a ...
Ava, Olivia, and Landon Langenhop were all born with a rare and life-threatening immune disorder called severe leukocyte ...
Zydus Lifesciences' wholly owned subsidiary Sentynl Therapeutics has entered into an agreement with Korea-based PRG S&T to license an investigational molecule, Progerinin (SLC-D011), ...
Living with a rare disease often means years of uncertainty, misdiagnosis, and limited treatment options. But advances in ...
As the discussion drifted to how the Covid pandemic impacted our lives and our approach towards health, hygiene, and immunity, Milind Soman pointed out that the biggest message of the pandemic was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results